Skip to main content
SpringerLink
Log in

Matrix Metalloproteinase Inhibitors for Cancer Therapy

Are Reports of Their Death Exaggerated?

  • Emerging Issues
  • Published:
Pharmaceutical Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matrix Metalloproteinase Inhibitors for Cancer Therapy. Pharmaceutical Innovation 11, 17–20 (2002). https://doi.org/10.1007/BF03265431

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03265431

Keywords

Search

Navigation